183
Views
9
CrossRef citations to date
0
Altmetric
Drug Evaluation

Alfuzosin: an α1-receptor blocker for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia

Pages 583-596 | Published online: 23 Mar 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Denise Kreutzwiser & Alice Tseng. (2016) Drug interactions between antiretrovirals and drugs used to treat benign prostatic hyperplasia/lower urinary tract symptoms. Expert Opinion on Drug Metabolism & Toxicology 12:10, pages 1211-1224.
Read now

Articles from other publishers (8)

Jae-Hyun Seo, Jae Sang Han, Yunhee Lee, Jun-Pyo Myong & U-Syn Ha. (2022) Fall risk related to subtype-specific alpha-antagonists for benign prostatic hyperplasia: a nationwide Korean population-based cohort study. World Journal of Urology 40:12, pages 3043-3048.
Crossref
Mina Wadie, Ezzat M. Abdel-Moety, Mamdouh R. Rezk & Mahmoud A. Tantawy. (2021) Eco-friendly chiral HPLC method for determination of alfuzosin enantiomers and solifenacin in their newly pharmaceutical combination: Method optimization via central composite design. Microchemical Journal 165, pages 106095.
Crossref
Mahmoud A. Tantawy, Soheir A. Weshahy, Mina Wadie & Mamdouh R. Rezk. (2020) A novel HPLC-DAD method for simultaneous determination of alfuzosin and solifenacin along with their official impurities induced via a stress stability study; investigation of their degradation kinetics . Analytical Methods 12:26, pages 3368-3375.
Crossref
Wei-Heng Kao, Chang-Fu Kuo, I-Jun Chou, Lai-Chu See, Wen-Kuan Huang, Meng-Jiun Chiou, Weiya Zhang, Michael Doherty, Chun-Chieh Wang, Jun-Te Hsu, Hsien-Hsin Chen & Ji-Hong Hong. (2018) Prostate-selective α antagonists increase fracture risk in prostate cancer patients with and without a history of androgen deprivation therapy: a nationwide population-based study. Oncotarget 9:4, pages 5263-5273.
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 201 214 .
J. H. Chung, J. Y. Lee, D. H. Kang, J. K. Jo, J. W. Lee, S. H. Lee, K. S. Lee, T. H. Kim, J. H. Han & S. W. Lee. (2013) Evaluation of patient outcome after discontinuation of alfuzosin treatment for benign prostatic hyperplasia: a multicentre, prospective study. International Journal of Clinical Practice 67:9, pages 870-875.
Crossref
Tarun P. Pagariya & Sanjay B. Patil. (2013) Development and optimization of multiparticulate drug delivery system of alfuzosin hydrochloride. Colloids and Surfaces B: Biointerfaces 102, pages 171-177.
Crossref
Hiren N. Mistri, Arvind G. Jangid, Ashutosh Pudage, Dhiraj M. Rathod & Pranav S. Shrivastav. (2008) Highly sensitive and rapid LC–ESI-MS/MS method for the simultaneous quantification of uroselective α1-blocker, alfuzosin and an antimuscarinic agent, solifenacin in human plasma. Journal of Chromatography B 876:2, pages 236-244.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.